AS-549 Enriched Tryptic Soy Agar with Nalidixic Acid and Vancomycin (ETSA-NV) is an enriched, selective, and differential medium intended for the cultivation and isolation of most…
AS-549 Enriched Tryptic Soy Agar with Nalidixic Acid and Vancomycin (ETSA-NV) is an enriched, selective, and differential medium intended for the cultivation and isolation of most gram-negative anaerobic and other fastidious bacteria. Pre-reduced anaerobically sterilized (PRAS). 100 x 15 mm agar plate. Transparent yellow/red. 4 plates per pack.
Who Else Makes It
Registered in Guangdong.
Record
Regulatory record for Pras Enriched Tryptic Soy Agar with Nalidixic Acid and Vancomycin (Etsa-NV) | Listed by | Anaerobe Systems, United States |
| FDA product code | JSI |
| Device type | Culture Media, Selective And Differential |
| Device class | Class 1 |
| Regulation | 21 CFR 866.2360 |
| Establishment | Complaint-file establishment, Manufacturer |
| Premarket notification | Exempt |
| Record published | 2020-05-01 |
Specifications
Specifications | MRI safety | Labeling does not contain MRI Safety Information |
| Single use | Yes |
| Label carries | lot or batch number, expiry date |
| Storage | Storage environment temperature 20 to 25 °C |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.